Overview
Exit Award only
Upon successful completion of Part I modules to the value of 60 credits, students may opt to exit the MSc (Industrial Pharmaceutical Sciences, Operations and Management) and be conferred with a Postgraduate Diploma in Industrial Pharmaceutical Sciences, Operations and Management. Students taking an exit award cannot subsequently register for the remainder of the Masters.
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
Full-time
Module List
Code |
Title |
Credits |
| |
PF6026 | Pharmaceutical Technology and Unit Operations with Regulatory Insights | 5 |
PF6027 | Pharmaceutical GxP and Regulatory Science | 5 |
PF6032 | Bioprocessing Unit Operations | 5 |
PF6033 | Pharmaceutical Analysis and Analytics | 5 |
PF6045 | Pharmaceutical Operations & Management | 10 |
BU6514 | Business Case for Analytics | 5 |
MG6024 | Developing Management and Leadership Skills for Organisational Effectiveness | 10 |
MG6025 | Project Management | 5 |
| 10 |
| Biotechnology-derived and Advanced Therapy Medicinal Products (ATMPs) (5) | |
| Digital Transformation in the (Bio)pharma Industry (5) | |
| Lean Six Sigma for BioPharma (10) | |
| Contract and External Manufacturing in Pharma and Biopharma (10) | |
Total Credits | 60 |
Part-time
Module List
Code |
Title |
Credits |
| |
| |
MG6025 | Project Management | 5 |
PF6026 | Pharmaceutical Technology and Unit Operations with Regulatory Insights | 5 |
PF6027 | Pharmaceutical GxP and Regulatory Science | 5 |
PF6028 | Process Control and Validation for Pharmaceutical Processes | 5 |
PF6032 | Bioprocessing Unit Operations | 5 |
PF6033 | Pharmaceutical Analysis and Analytics | 5 |
| |
BU6514 | Business Case for Analytics | 5 |
MG6024 | Developing Management and Leadership Skills for Organisational Effectiveness | 10 |
PF6034 | Pharmaceutical Operations | 5 |
| 10 |
| Biotechnology-derived and Advanced Therapy Medicinal Products (ATMPs) (5) | |
| Digital Transformation in the (Bio)pharma Industry (5) | |
| Lean Six Sigma for BioPharma (10) | |
| Contract and External Manufacturing in Pharma and Biopharma (10) | |
Total Credits | 60 |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for Postgraduate Diploma in Industrial Pharmaceutical Sciences, Operations and Management (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
1
1-1
Design, differentiate, and execute biopharmaceutical unit processes and analytical methods in a good manufacturing practice (GMP) environment.
1-2
2
Critique the theoretical aspects of quality systems, regulatory processes, and validation approaches.
1-3
3
Appraise common manufacturing issues encountered in the biopharmaceutical industry using scientific problem solving and data analysis.
1-4
4
Apply Lean Six Sigma, supply chain, and project management principles within an operations environment in the pharmaceutical sciences sector and beyond.
1-6
5
Collaborate, lead, and manage effectively within the workplace through the application of leadership, organisational dynamics, and management theory.
1-7
6
Evaluate, identify, and describe trends in digital transformation, industry 4.0 as applied to the biopharma industry (Pharma 4.0)
1-8
7
Compare and contrast data and data analytics and appraise how data analytics can be used to manage and improve manufacturing processes in the biopharma industry.